121 related articles for article (PubMed ID: 17220468)
1. Hypokalemia, cardiac failure, and reporting NXY-059 safety for acute stroke.
Serebruany VL
J Cardiovasc Pharmacol Ther; 2006 Dec; 11(4):229-31. PubMed ID: 17220468
[TBL] [Abstract][Full Text] [Related]
2. NXY-059: review of neuroprotective potential for acute stroke.
Fong JJ; Rhoney DH
Ann Pharmacother; 2006 Mar; 40(3):461-71. PubMed ID: 16507608
[TBL] [Abstract][Full Text] [Related]
3. NXY-059. Centaur.
Lapchak PA
Curr Opin Investig Drugs; 2002 Dec; 3(12):1758-62. PubMed ID: 12528313
[TBL] [Abstract][Full Text] [Related]
4. Safety, tolerability and pharmacokinetics of escalating doses of NXY-059 in healthy young and elderly subjects.
Wemer J; Cheng YF; Nilsson D; Reinholdsson I; Fransson B; Lanbeck Vallén K; Nyman L; Eriksson C; Björck S; Schulman S
Curr Med Res Opin; 2006 Sep; 22(9):1813-23. PubMed ID: 16968585
[TBL] [Abstract][Full Text] [Related]
5. Nitrone-related therapeutics: potential of NXY-059 for the treatment of acute ischaemic stroke.
Maples KR; Green AR; Floyd RA
CNS Drugs; 2004; 18(15):1071-84. PubMed ID: 15581379
[TBL] [Abstract][Full Text] [Related]
6. A phase 1, placebo-controlled, randomised, double-blind (within dose panels) study evaluating the safety, tolerability and pharmacokinetics of intravenous NXY-059 in Japanese subjects.
Watabe M; Cheng YF; Nilsson D; Itoh Y; Kumagai Y
Curr Med Res Opin; 2007 Aug; 23(8):1849-57. PubMed ID: 17605894
[TBL] [Abstract][Full Text] [Related]
7. Tolerability of NXY-059 at higher target concentrations in patients with acute stroke.
Lees KR; Barer D; Ford GA; Hacke W; Kostulas V; Sharma AK; Odergren T;
Stroke; 2003 Feb; 34(2):482-7. PubMed ID: 12574564
[TBL] [Abstract][Full Text] [Related]
8. NXY-059 does not affect bleeding time in healthy volunteers: a randomized, double-blind, placebo-controlled, 3-period crossover phase I study.
Nilsson D; Wemer J; Cheng YF; Reinholdsson I; Englund G; Egberg N; Schulman S
J Clin Pharmacol; 2007 Feb; 47(2):264-72. PubMed ID: 17244778
[TBL] [Abstract][Full Text] [Related]
9. A critical appraisal of the NXY-059 neuroprotection studies for acute stroke: a need for more rigorous testing of neuroprotective agents in animal models of stroke.
Savitz SI
Exp Neurol; 2007 May; 205(1):20-5. PubMed ID: 17408618
[TBL] [Abstract][Full Text] [Related]
10. The nitrone disodium 2,4-sulphophenyl-N-tert-butylnitrone is without cytoprotective effect on sodium nitroprusside-induced cell death in N1E-115 neuroblastoma cells in vitro.
Hainsworth AH; Bhuiyan N; Green AR
J Cereb Blood Flow Metab; 2008 Jan; 28(1):24-8. PubMed ID: 17554259
[TBL] [Abstract][Full Text] [Related]
11. NXY-059 for acute ischemic stroke: the promise of neuroprotection is finally realized?
Fisher M
Stroke; 2006 Oct; 37(10):2651-2. PubMed ID: 16946143
[No Abstract] [Full Text] [Related]
12. NXY-059: a hopeful sign in the treatment of stroke.
Hess DC
Stroke; 2006 Oct; 37(10):2649-50. PubMed ID: 16946156
[No Abstract] [Full Text] [Related]
13. NXY 059: CPI 22, NXY 059G.
Adis International Ltd
Drugs R D; 2003; 4(4):254-7. PubMed ID: 12848592
[TBL] [Abstract][Full Text] [Related]
14. Development of the nitrone-based spin trap agent NXY-059 to treat acute ischemic stroke.
Lapchak PA; Araujo DM
CNS Drug Rev; 2003; 9(3):253-62. PubMed ID: 14530797
[TBL] [Abstract][Full Text] [Related]
15. NXY-059 does not significantly interact with furosemide in healthy volunteers.
Strid S; Nilsson D; Borgå O; Wemer J; Grahnén A
J Clin Pharmacol; 2006 Dec; 46(12):1417-25. PubMed ID: 17101741
[TBL] [Abstract][Full Text] [Related]
16. Tolerability and pharmacokinetics of the nitrone NXY-059 in patients with acute stroke.
Lees KR; Sharma AK; Barer D; Ford GA; Kostulas V; Cheng YF; Odergren T
Stroke; 2001 Mar; 32(3):675-80. PubMed ID: 11239186
[TBL] [Abstract][Full Text] [Related]
17. Oxygen free radical traps for the treatment of ischemia-associated organ injury.
Jackson DM; Sammut IA
Curr Opin Investig Drugs; 2004 Jan; 5(1):50-4. PubMed ID: 14983973
[TBL] [Abstract][Full Text] [Related]
18. Investigating the free radical trapping ability of NXY-059, S-PBN and PBN.
Williams HE; Claybourn M; Green AR
Free Radic Res; 2007 Sep; 41(9):1047-52. PubMed ID: 17729123
[TBL] [Abstract][Full Text] [Related]
19. Future of neuroprotection for acute stroke: in the aftermath of the SAINT trials.
Savitz SI; Fisher M
Ann Neurol; 2007 May; 61(5):396-402. PubMed ID: 17420989
[TBL] [Abstract][Full Text] [Related]
20. NXY-059: a neuroprotective agent in acute stroke.
Wang CX; Shuaib A
Int J Clin Pract; 2004 Oct; 58(10):964-9. PubMed ID: 15587776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
